Welcome to Bioscience Technology’s new series Bioscience Bulletin, where we bring you the five most popular headlines from the week.
The goal for many cancer patients is to reach the five-year, disease-free mark, but new research...
An ‘exhausted’ army of immune cells may not be able to fight off infection, but if its soldiers...
Mistakes on memory and thought tests may give an indication of the future onset of Alzheimer’s,...
A former Iowa State University scientist who altered blood samples to make it appear he had achieved a breakthrough toward a potential vaccine against HIV was sentenced Wednesday to more than 4 1/2 years in prison for making false statements in research reports.
One reason ovarian cancer is so deadly: it turns off immune cells that try to fight it. A Weill Cornell Medical College team has found that disarming a gene called XBP1 rearms immune cells—which successfully combat ovarian cancer.
Oxford Gene Technology (OGT) released a new microarray designed to improve the accuracy and efficiency of cancer research. The CytoSure Cancer +SNP array (4x180k) combines long oligo array comparative genomic hybridisation (aCGH) probes with fully validated single nucleotide polymorphism (SNP) content.
Lysosomes, the “garbage disposal” systems of cells, are found in great abundance near the amyloid plaques in the brain that are a hallmark of Alzheimer’s disease. Scientists have long assumed that their presence was helpful — that they were degrading the toxic proteins that trigger amyloid plaque formation.
The experimental treatment uses a genetically modified virus to deliver a missing gene into the cerebrospinal fluid of children with giant axonal neuropathy (GAN).
Scientists are one step closer to engineering a tool that could one day arm the body’s immune system to fight HIV — and win. The new technique harnesses the regenerative capacity of stem cells to generate an immune response to the virus.
Many stroke patients have a new treatment option -- if they seek help fast enough to get it. New guidelines endorse using a removable stent to open clogged arteries causing a stroke.
New animal research reveals fundamental sex differences in how pain is processed.
A new study identifies new immune molecules that protect against deadly Marburg virus, a relative of Ebola virus.
A new study suggests that errors on memory and thinking tests may signal Alzheimer’s up to 18 years before the disease can be diagnosed.
High levels of DNA damage in nerve cells can lead to dementia, researchers have found.
An implantable, microchip-based device may soon replace the injections and pills now needed to treat chronic diseases.
Nearly two-thirds of Americans with Alzheimer's disease are women, and now some scientists are questioning the long-held assumption that it's just because they tend to live longer than men.
A new test can accurately diagnose the Ebola virus disease within minutes at the point of care, providing clinicians with crucial, on-the-spot information for treating patients and containing outbreaks.
Trametinib inhibits the same signal pathway in flies and humans and could thus conceivably also extend life expectancy in humans.
Honokiol, from magnolia bark, shuts down cancer cells in lab.
Old beliefs upended as dementia research yields new locations for word and sentence comprehension.
A new study suggests that people with a genetic predisposition to high blood pressure have a lower risk for Alzheimer's disease.
Researchers have now managed to grow the types of neurons affected by Parkinson's starting from neuronal stem cells in a three-dimensional cell culture system.
Restoring the low levels of the chemical serotonin may help improve brain function and reduce impulsivity in some dementia patients, according to researchers.
An international team of scientists has uncovered key structural differences in the brains of parrots that may explain the birds' unparalleled ability to imitate sounds and human speech.
One of the world’s leading Alzheimer’s researchers doubles as a guest organist for Aerosmith.
Researchers have engineered particles, known as “phagemids,” capable of producing toxins that are deadly to targeted bacteria.
Scientists study how new impressions are transferred in long-term memory.
Researchers studying how the brain controls movement in people with paralysis, related to their diagnosis of Lou Gehrig’s disease, have found that groups of neurons work together, firing in complex rhythms to signal muscles about when and where to move.
- Page 1